SEC 13F Intelligence

Norges Bank / ABT

Norges Bank’s Abbott Laboratories Position

Does Norges Bank own Abbott Laboratories (ABT)? Not currently — the last reported position was 23.46M shares worth $2.9B in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2.9B
Q4 2025
Shares
23.46M
% of Portfolio
+0.31%
Quarters Held
23
position exited

Position History ABT

Reported value by quarter
Q1 ’19: $1.1BQ1 ’19Q2 ’19: $1.1BQ3 ’19: $1.3BQ1 ’20: $1.3BQ1 ’20Q2 ’20: $1.5BQ3 ’20: $1.5BQ1 ’21: $1.3BQ1 ’21Q2 ’21: $1.6BQ3 ’21: $1.9BQ1 ’22: $2.0BQ1 ’22Q2 ’22: $1.9BQ3 ’22: $1.9BQ4 ’22: $1.9BQ4 ’22Q2 ’23: $1.7BQ3 ’23: $1.6BQ4 ’23: $2.1BQ4 ’23Q1 ’24: $1.8BQ2 ’24: $4.1BQ3 ’24: $1.8BQ3 ’24Q4 ’24: $2.4BQ1 ’25: $2.3BQ2 ’25: $3.0BQ2 ’25Q4 ’25: $2.9Bfilingsflow.com
QuarterSharesValue% of Portfolio
Q4 202523.46M$2.9B+0.31%
Q2 202522.25M$3.0B+0.38%
Q1 202520.18M$2.3B+0.36%
Q4 202420.98M$2.4B+0.31%
Q3 202418.71M$1.8B+0.37%
Q2 202438.80M$4.1B+0.35%
Q1 202417.70M$1.8B+0.39%
Q4 202319.22M$2.1B+0.37%
Q3 202316.24M$1.6B+0.42%
Q2 202315.86M$1.7B+0.45%
Q4 202217.25M$1.9B+0.46%
Q3 202216.48M$1.9B+0.43%
Q2 202216.65M$1.9B+0.42%
Q1 202217.10M$2.0B+0.47%
Q3 202117.17M$1.9B+0.50%
Q2 202117.17M$1.6B+0.45%
Q1 202117.04M$1.3B+0.48%
Q3 202017.75M$1.5B+0.45%
Q2 202017.90M$1.5B+0.47%
Q1 202016.77M$1.3B+0.43%
Q3 201917.75M$1.3B+0.42%
Q2 201918.41M$1.1B+0.39%
Q1 201917.67M$1.1B+0.38%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Norges Bank’s full portfolio or all institutional holders of ABT.